Notaufnahme up2date, Table of Contents Notaufnahme up2date 2024; 06(03): 289-312DOI: 10.1055/a-2079-3194 Kinder, Geburt und Schwangerschaft Notfälle in der Schwangerschaft und Notfallgeburt Lydia Hottenbacher , Mandy Mangler Recommend Article Abstract Buy Article All articles of this category Notfälle in der Schwangerschaft sind selten und stellen für alle Behandelnden eine Herausforderung dar – es geht immer um zwei Leben, das der Mutter und das des noch ungeborenen Kindes. Durch die Seltenheit bekommt auch kaum ein präklinisch Behandelnder ausreichend Routine, auch in einer Notaufnahme, in der häufig auch Kolleg*innen am Beginn ihrer Weiterbildung eingesetzt werden. Schlüsselwörter SchlüsselwörterGeburtshilfe - Hypertensive Erkrankungen - Nabelschnur - Blutungen Full Text References Literatur 1 Kassenärztliche Bundesvereinigung (KBV). Mutterpass 1.1.0. Stand 04.01.2022. Accessed May 08, 2024 at: https://mio.kbv.de/display/MP1X1X0/Mutterpass+1.1.0 2 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e.V. (DGGG. ). S2k-Leitlinie Prävention und Therapie der Frühgeburt. AWMF-Registernr. 015–015. Version 5.0. Stand 01.10.2022. Accessed May 08, 2024 at: https://register.awmf.org/de/leitlinien/detail/015–025 3 perinatalzentren.org. Häufig gestellte Fragen. Accessed May 08, 2024 at: https://perinatalzentren.org/informationen/faq/#collapse70 4 Gemeinsamer Bundesausschuss. Qualitätssicherungs-Richtlinie Früh- und Reifgeborene. Stand 19.01.2024. Accessed May 08, 2024 at: https://www.g-ba.de/richtlinien/41/ 5 Aasheim V, Nilsen ABV, Reinar LM. et al. Perineal techniques during the second stage of labour for reducing perineal trauma. Cochrane Database Syst Rev 2017; 6: CD006672 6 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e.V. (DGGG). S3-Leitlinie Die vaginale Geburt am Termin. Version 1.0. Stand 22.12.2020. AWMF-Registernr. 015–083. Accessed May 08, 2024 at: https://register.awmf.org/de/leitlinien/detail/015–083 7 National Institute for Health and Care-Excellence (NICE). Intrapartum Care. NICE guideline [NG235]. Published 29 September 2023. Accessed May 08, 2024 at: https://www.nice.org.uk/guidance/ng235 8 Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr Res Anaesth Analg 1953; 32: 261-267 9 Apgar V, Holaday DA, James LS. et al. Evaluation of the newborn infant; second report. J Am Med Assoc 1958; 168: 1985-1988 10 Weiner GM, Zaichkin J. Textbook of Neonatal Resuscitation. Itasca: American Academy of Pediatrics; 2021 11 Krause M. Der Vierfüßlerstand – eine optimale Gebärhaltung bei Beckenendlage. Hebamme 2007; 20: 164-167 12 Harder U, Mack S. BEL-Geburt im Vierfüßler: interventionsarme Geburtshilfe. Hebamme 2015; 28: 16-22 13 Uhl B. Beckenendlage (BEL). In: Uhl B. Gynäkologie und Geburtshilfe compact. Stuttgart: Thieme; 2023 14 Carbillon L, Benbara A, Tigaizin A. et al. Revisiting the management of term breech presentation: a proposal for overcoming some of the controversies. BMC Pregnancy Childbirth 2020; 20: 263 15 Hasan R, Baird DD, Herring AH. et al. Patterns and predictors of vaginal bleeding in the first trimester of pregnancy. Ann Epidemiol 2010; 20: 524-531 16 Koifman A, Levy A, Zaulan Y. et al. The clinical significance of bleeding during the second trimester of pregnancy. Arch Gynecol Obstet 2008; 278: 47 17 Everett C. Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice. BMJ 1997; 315: 32 18 Fan D, Wu S, Liu L. et al. Prevalence of antepartum hemorrhage in women with placenta previa: a systematic review and meta-analysis. Sci Rep 2017; 7: 40320 19 Cotton DB, Read JA, Paul RH. et al. The conservative aggressive management of placenta previa. Am J Obstet Gynecol 1980; 137: 687 20 Dadak C. Geburtshilfliche Blutungen. J Gynäkol Endokrinol AT 2023; 33: 56-58 21 Parry Smith WR, Papadopoulou A, Thomas E. et al. Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev 2020; 11: CD012754 22 Della Corte L, Saccone G, Locci M. et al. Tranexamic acid for treatment of primary postpartum hemorrhage after vaginal delivery: a systematic review and meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med 2020; 33: 869-874 23 Ananth CV, Smulian JC, Demissie K. et al. Placental abruption among singleton and twin births in the United States: risk factor profiles. Am J Epidemiol 2001; 153: 771 24 Maeland KS, Morken NH, Schytt E. et al. Placental abruption in immigrant women in Norway: A population-based study. Acta Obstet Gynecol Scand 2021; 100: 658 25 Lueth A, Blue N, Silver RM. et al. Prospective evaluation of placental abruption in nulliparous women. J Matern Fetal Neonatal Med 2022; 35: 8603 26 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e.V. (DGGG). S2k-Leitlinie Hypertensive Schwangerschaftserkrankungen: Diagnostik und Therapie. Version 6.0. Stand 01.05.2019. AWMF-Registernr. 015–018. Accessed May 08, 2024 at: https://www.awmf.org/leitlinien/detail/II/015–018.html 27 Rath W. Präeklampsie: aktuelles Management. Hebamme 2008; 21: 84-89 28 Schlembach D. Homuth V, Dechend R. Treating Hypertension in Pregnancy. Curr Hypertens Rep 2015; 17: 63 29 National Institute for Health and Excellence. Hypertension in pregnancy diagnosis and management. NICE guideline [NG133]. Last updated 17 April 2023. Accessed May 08, 2024 at: https://www.nice.org.uk/guidance/ng133 30 Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol [Anonym]. 2013; 122: 1122-1131 31 Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996; 335: 257-265 32 Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. Obstet Gynecol [Anonym]. 2011; 118: 1465-1468 33 Magee LA, von Dadelszen P, Rey E. et al. [59-or]: The control of hypertension in pregnancy study (CHIPS) randomized controlled trial – Is the type of antihypertensive important?. Pregnancy Hypertens 2015; 5: 30-31 34 Vest AR, Cho LS. Hypertension in Pregnancy. Curr Atheroscler Rep 2014; 16: 395 35 Solomon CG, Greene MF. Control of hypertension in pregnancy – If some is good, is more worse?. N Engl J Med 2015; 372: 475-476 36 Redman CW, Roberts JM. Management of pre-eclampsia. Lancet 1993; 341: 1451-1454 37 Coetzee EJ, Dommisse J, Anthony J. A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol 1998; 105: 300-303 38 Altman D, Carroli G, Duley L. et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002; 359: 1877-1890 39 Sibia B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365: 785-799 40 Wu P, Chew-Graham CA, Maas AH. et al. Temporal Changes in Hypertensive Disorders of Pregnancy and Impact on Cardiovascular and Obstetric Outcomes. Am J Cardiol 2020; 125: 1508-1516 41 Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2001; 357: 209-215 42 von Dadelszen P, Ornstein MP, Bull SB. et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000; 355: 87-92 43 Odendaal HJ, Pattinson RC, Bam R. et al. Aggressive or expectant management for patients with severe preeclampsia between 28–34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 1990; 76: 1070-1075 44 Haddad B, Deis S, Goffinet F. et al. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation. Am J Obstet Gynecol 2004; 190: 1590-1595 discussion 1595–1597 45 Sibai BM, Mercer BM, Schiff E. et al. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994; 171: 818-822 46 Schaefer C, Spielmann H, Vetter K. et al. Arzneimittel in Schwangerschaft und Stillzeit. München: Urban & Fischer Verlag/Elsevier GmbH; 2011 47 Wacker JR, Wagner BK, Briese V. et al. Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil. Eur J Obstet Gynecol Reprod Biol 2006; 127: 160-165 48 Duley L, Henderson-Smart DJ, Walker GJ. et al. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev 2010; 2010: CD000127 49 Duley L, Gülmezoglu AM, Henderson-Smart DJ. et al. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2010; 2010: CD000025 50 Duley L, Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev Update in: Cochrane Database Syst Rev 2010; 10: CD000128PubMed: 14583910 2003; 4: CD000128 51 Duley L, Gülmezoglu AM, Chou D. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database Syst Rev 2010; 2010: CD002960 52 Duley L. Pre-eclampsia, eclampsia, and hypertension. BMJ Clin Evid 2011; 2011: 1402 53 Duley L, Matar HE, Almerie MQ. et al. Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. Cochrane Database Syst Rev Update in: Cochrane Database Syst Rev 2023; 10: CD007388. 2010; 2010: CD007388 54 Pratt JJ, Niedle PS, Vogel JP. et al. Alternative regimens of magnesium sulfate for treatment of preeclampsia and eclampsia: a systematic review of non-randomized studies. Acta Obstet Gynecol Scand 2016; 95: 144-156 55 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e.V. (DGGG). S2k-Leitlinie Intrauterine Wachstumsrestriktion (IUGR Leitlinie). Version 1.0. Stand 01.05.2017. AWMF-Registernr. 015–080. Accessed May 08, 2024 at: https://register.awmf.org/de/leitlinien/detail/015–080 56 Rath W. Das HELLP-Syndrom – eine interdisziplinäre Herausforderung. Dtsch Ärztebl 1998; 95: A-2997/B-2555/-C-2367 57 Rath W, Loos W, Kuhn W. Das HELLP-Syndrom. Zentralbl Gynäkol 1994; 116: 195-201 58 Benaceraff BR, Frigoletto FD, Martini C. Sonographic findings in severe pre- eclampsia twenty-four hours prior to clinical signs. Am J Obstet Gynecol 1985; 152: 684-685 59 Immanuel Albertinen Diakonie. Sonographie-Atlas. 1. HELLP-Leber. Accessed May 08, 2024 at: https://sonographiebilder.de/hellp 60 Minakami H, Sugimoto H, Manaka C. et al. HELLP-syndrome: CT evaluation. Gynecol Obstet Invest 1994; 38: 28-30 61 Mikolajczyk RT, Kraut AA, Garbe E. Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD). Pharmacoepidemiol Drug Saf 2013; 22: 873-880
